LONGEVERON LLC Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement between Longeveron, Inc. and Nataliya Agafonova, M.D. dated June 21, 2023
LONGEVERON LLC
Biotechnology
CA
2024
Letter Agreement between Longeveron, Inc. and Lisa Locklear, dated July 14,2023
LONGEVERON LLC
Biotechnology
CA
2024
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
LONGEVERON LLC
Biotechnology
2024
Dealer-Manager Agreement, dated August 14, 2023, between Longeveron Inc. and R.F. Lafferty & Co., Inc
LONGEVERON LLC
Biotechnology
NY
2023
Form of Dealer-Manager Agreement with R.F. Lafferty & Co. Inc
LONGEVERON LLC
Biotechnology
NY
2023
Agreement, dated February 22, 2023
LONGEVERON LLC
Biotechnology
CA
2023
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
LONGEVERON LLC
Biotechnology
2022
Underwriter Warrants issued February 17, 2021
LONGEVERON LLC
Biotechnology
NY
2021
Certificate of Conversion of Longeveron LLC
LONGEVERON LLC
Biotechnology
2021
Plan of Conversion
LONGEVERON LLC
Biotechnology
DE
2021
Form of Underwriter Warrants
LONGEVERON LLC
Biotechnology
NY
2021
Form of Certificate of Conversion of Longeveron LLC
LONGEVERON LLC
Biotechnology
2021
Form of Plan of Conversion
LONGEVERON LLC
Biotechnology
DE
2021
National Institutes of Health Grant to University of Maryland Baltimore, dated September 9, 2020
LONGEVERON LLC
Biotechnology
2021
National Institutes of Health Grant to Longeveron LLC, dated June 24, 2020
LONGEVERON LLC
Biotechnology
2021
National Institutes of Health Grant to Longeveron LLC, dated April 26, 2019
LONGEVERON LLC
Biotechnology
2021
Alzheimers Association Grant to Longeveron LLC, dated April 1, 2019
LONGEVERON LLC
Biotechnology
2021